Skip to main content

Tonix Pharmaceuticals Holding Corp. (TNXP)

NASDAQ: TNXP · IEX Real-Time Price · USD
0.505
0.029 (6.18%)
At close: Nov 26, 2021 1:00 PM
0.539
0.034 (6.653%)
After-hours:Nov 26, 2021 4:59 PM EST
Market Cap221.99M
Revenue (ttm)n/a
Net Income (ttm)-79.76M
Shares Out439.59M
EPS (ttm)-0.28
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume15,272,108
Open0.534
Previous Close0.476
Day's Range0.481 - 0.510
52-Week Range0.501 - 2.120
Beta1.14
AnalystsStrong Buy
Price Target3.75 (+642.6%)
Earnings DateNov 8, 2021

About TNXP

Tonix Pharmaceuticals Holding Corp. discovers, acquires, develops, and licenses small molecules and biologics to treat and prevent human diseases and alleviate suffering. Its immunology product candidates include vaccines to prevent infectious diseases and biologics to address immunosuppression, cancer, and autoimmune diseases; and central nervous system (CNS) product candidates comprise small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions. The company's lead vaccine candidate is TNX-1800, a live replic...

IndustryBiotechnology
Founded2007
CEOSeth Lederman
Employees26
Stock ExchangeNASDAQ
Ticker SymbolTNXP
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for TNXP stock is "Strong Buy" and the 12-month stock price forecast is 3.75.

Price Target
$3.75
(642.57% upside)
Analyst Consensus: Strong Buy

News

Why Tonix Pharmaceuticals Is Up by 6% Today

The company's path to regulatory approval for a key pipeline drug just got a bit shorter.

4 days ago - The Motley Fool

FDA Clears Tonix Pharma's Human Trial With Intranasal Oxytocin For Migraine

The FDA has signed off Tonix Pharmaceuticals Holding Corp's (NASDAQ: TNXP) Investigational New Drug (IND) Application to initiate Phase 2 study of TNX-1900 for migraine.  TNX-1900 is intranasal potentia...

4 days ago - Benzinga

TNXP Stock Alert: The Migraine News Sending Tonix Pharmaceuticals Soaring

TNXP stock is soaring 20% on Tuesday after Tonix Pharmaceuticals' treatment for migraines received a key FDA clearance. The post TNXP Stock Alert: The Migraine News Sending Tonix Pharmaceuticals Soaring...

4 days ago - InvestorPlace

Tonix Pharmaceuticals Announces FDA Clearance of the IND for Potentiated Intranasal Oxytocin (TNX-1900) for the Preve...

Approximately Four Million in U.S. Suffer from Chronic Migraine

4 days ago - GlobeNewsWire

Tonix Pharmaceuticals Announces Publication of Paper on Antiviral SARS-CoV-2 Inhibitor, TNX-3500, in JCI Insight

Early Studies in vitro Show that TNX-3500 is a Potent Antiviral Against Multiple Variants of SARS-CoV-2, the Cause of COVID-19, and Potentiates Remdesivir Early Studies in vitro Show that TNX-3500 is a ...

5 days ago - GlobeNewsWire

Why Tonix Pharmaceuticals Holding Zoomed Higher Today

The company secures a potentially crucial piece of intellectual property.

1 week ago - The Motley Fool

Tonix Pharmaceuticals Presents Phase 1 Formulation Development Data for TNX-601 CR in a Poster Presentation at CNS Su...

Phase 2 Trial of TNX-601 CR for the Treatment of Major Depressive Disorder Expected to Start First Half 2022 Phase 2 Trial of TNX-601 CR for the Treatment of Major Depressive Disorder Expected to Start ...

2 weeks ago - GlobeNewsWire

Tonix Pharmaceuticals Presents Positive Results from Phase 3 RELIEF Study of TNX-102 SL for the Management of Fibromy...

CHATHAM, N.J., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced an oral presentati...

2 weeks ago - GlobeNewsWire

Tonix Pharmaceuticals Reports Third Quarter 2021 Financial Results and Operational Highlights

Expansion of Internal Research and Development Capabilities Underway to Accelerate Infectious Disease Programs and Prepare for Future Pandemic Responses

2 weeks ago - GlobeNewsWire

5 Penny Stocks To Watch For November With Potential Biotech Catalysts

Biotech penny stocks to watch with upcoming events this week. The post 5 Penny Stocks To Watch For November With Potential Biotech Catalysts appeared first on Penny Stocks to Buy, Picks, News and Inform...

Other symbols:AGENCRVSLQDAPHAS
3 weeks ago - PennyStocks

Tonix Pharmaceuticals Announces Ribbon-Cutting Ceremony for its Infectious Disease R&D Center in Maryland

Internal R&D Capabilities Expected to Support U.S. Pandemic Preparedness with Accelerated Discovery and Development of Vaccines and Antivirals Against COVID-19 and Other Infectious Diseases

1 month ago - GlobeNewsWire

Tonix Pharmaceuticals to Participate in the A.G.P. Virtual Healthcare Conference

CHATHAM, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced that Seth Lederman, M.D....

1 month ago - GlobeNewsWire

Tonix Pharmaceuticals Announces Completion of Acquisition of Infectious Disease R&D Center in Frederick, Maryland

R&D Center is Expected to Accelerate Internal Discovery and Development of Vaccines and Antiviral Drugs Against COVID-19, its Variants and Other Infectious Diseases

1 month ago - GlobeNewsWire

Tonix Pharmaceuticals Expands Research Collaboration to Develop Precision Medicine Techniques for COVID-19 Vaccines a...

Collaboration Will Continue to Work Towards Identifying Biomarkers for Protective Immunity Against SARS-CoV-2

2 months ago - GlobeNewsWire

Tonix Pharmaceuticals to Present at the Cantor Virtual Global Healthcare Conference

CHATHAM, N.J., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederma...

2 months ago - GlobeNewsWire

Tonix Pharma Shares FDA Response For COVID-19 Vaccine Candidate Human Study

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) announced that it received the official written response from a Type B pre-Investigational New Drug (IND) meeting with the FDA for its COVID-19 vaccine ...

2 months ago - Benzinga

Why AMC, Clover, and Other Meme Stocks Are Tumbling Today

The notion that groups of individual investors can consistently organize efforts to push stock prices around is starting to crumble. At some point, companies must prove their stock's value.

Other symbols:AMCCLOVGMESKLZ
2 months ago - The Motley Fool

Why Meme Stocks GameStop, Naked, and Tonix Were on the Move Today

The stocks have been active ever since the FDA announced full approval of a COVID-19 vaccine.

Other symbols:GMENAKD
3 months ago - The Motley Fool

Why Shares of GameStop, Naked Brand Group, and Tonix Pharmaceuticals Were Soaring Today

The positive vaccine news seems to have kick-started meme stocks again.

Other symbols:GMENAKD
3 months ago - The Motley Fool

Best Penny Stocks to Buy Today? 4 You Need to Watch Right Now

Are tech penny stocks worth it or not? Check these 4 out for your watchlist The post Best Penny Stocks to Buy Today?

Other symbols:BOXLPHUNSONM
3 months ago - PennyStocks

Tonix Pharmaceuticals To Start Mid-Stage Long COVID Trial In Q4

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) received the official minutes from a Type B pre-Investigational New Drug Application (IND) meeting with the FDA. The meeting was related to TNX-102 SL1 ...

3 months ago - Benzinga

Tonix Pharmaceuticals Announces Results of Pre-IND Meeting with FDA for TNX-102 SL as a Potential Treatment for Long ...

Company Plans to Submit an IND to Support a Phase 2 Clinical Trial of TNX-102 SL for the Treatment of Long COVID

3 months ago - GlobeNewsWire

Why Meme Stocks AMC, GameStop, and Tonix Rocketed Higher Today

Monday's coronavirus vaccine news was a real shot in the arm for the trio.

Other symbols:AMCGME
3 months ago - The Motley Fool

Tonix Pharmaceuticals Reports Second Quarter 2021 Financial Results and Operational Highlights

Central Nervous System Pipeline Progressing with Two Phase 2 Studies (TNX-1300 and TNX-1900) and One Phase 3 Study (TNX-102 SL) Expected to Start This Year

3 months ago - GlobeNewsWire

What's Next for Robinhood Favorite Tonix Pharmaceuticals?

The small drugmaker is moving forward after disappointing clinical results.

Other symbols:HOOD
3 months ago - The Motley Fool